Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table 4 from High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study
  1. Home
  2. Publications
  3. Supplementary Table 4 from High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study

Supplementary Table 4 from High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study

Authors:
  • YGYan Gao
    Yan Gao
  • LPLiqin Ping
    Liqin Ping
  • CSChangguo Shan
    Changguo Shan
  • HHHe Huang
    He Huang
  • ZLZhiming Li
    Zhiming Li
  • HZHui Zhou
    Hui Zhou
  • MLMingyao Lai
    Mingyao Lai
  • LCLinbo Cai
    Linbo Cai
  • BBBing Bai
    Bing Bai
  • CHCheng Huang
    Cheng Huang
  • HCHaoqing Chen
    Haoqing Chen
  • XHXiaoyu Hong
    Xiaoyu Hong

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2643-3230.32696694
Abstract
Supplementary Table 4. The 475 genes in the Hemasalus panel.
Keywords
  • BIOMARKERS
  • CIRCULATING TUMOR CELLS/DNA/EXOSOMES
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • DRUG TARGETS
  • PROTEIN KINASE & PHOSPHATASE DRUG TARGETS
  • HEMATOLOGICAL CANCERS
  • LYMPHOMAS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.